Back to Authors

Moros, L

Mayo Clinic

Boehringer Ingelheim (Germany)

Citations 1

Effects of nintedanib in patients with progressive fibrosing interstitial lung disease associated with rheumatoid arthritis (RA-ILD) in the INBUILD trial*
Koschel, D, Matteson, E. L., Mueller, Heiko , Moros, L, Rohr, K B, Koschel, D, Kelly, Clive Anthony , Aringer, Martin , Burmester, Gerd R , Moros, Lizette, Rohr, K B, Kolb, Martin R.J.

Pneumologie | June 8, 2022 | Volume: 76 | Issue: S 01 | Pages: S21-S21

10.1055/s-0042-1747733 Get It